Aflatoxin Exposure and Associated Human Health Effects, a Review of Epidemiological Studies - PubMed (original) (raw)

Review

Aflatoxin Exposure and Associated Human Health Effects, a Review of Epidemiological Studies

Yun Yun Gong et al. Food Saf (Tokyo). 2016.

Abstract

Aflatoxins are fungal toxins that possess acute life threatening toxicity, carcinogenic properties and other potential chronic adverse effects. Dietary exposure to aflatoxins is considered a major public health concern, especially for subsistence farming communities in sub-Saharan Africa and South Asia, where dietary staple food crops such as groundnuts and maize are often highly contaminated with aflatoxin due to hot and humid climates and poor storage, together with low awareness of risk and lack of enforcement of regulatory limits. Biomarkers have been developed and applied in many epidemiological studies assessing aflatoxin exposure and the associated health effects in these high-risk population groups. This review discusses the recent epidemiological evidence for aflatoxin exposure, co-exposure with other mycotoxins and associated health effects in order to provide evidence on risk assessment, and highlight areas where further research is necessary. Aflatoxin exposure can occur at any stage of life and is a major risk factor for hepatocellular carcinoma, especially when hepatitis B infection is present. Recent evidence suggests that aflatoxin may be an underlying determinant of stunted child growth, and may lower cell-mediated immunity, thereby increasing disease susceptibility. However, a causal relationship between aflatoxin exposure and these latter adverse health outcomes has not been established, and the biological mechanisms for these have not been elucidated, prompting further research. Furthermore, there is a dearth of information regarding the health effects of co-exposure to aflatoxin with other mycotoxins. Recent developments of biomarkers provide opportunities for important future research in this area.

Keywords: aflatoxin exposure; biomarker; child growth; developing countries; hepatocellular carcinoma; immune suppression.

©2016 Food Safety Commission, Cabinet Office, Government of Japan.

PubMed Disclaimer

References

    1. Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010; 31: 71–82. 10.1093/carcin/bgp264 - DOI - PMC - PubMed
    1. International Agency for Research on Cancer IARC monographs on the evaluation of carcinogenic risks to humans; vol 56, Chemical agents and related occupations. IARC, Lyon. 2012; 100F: 1–599. - PMC - PubMed
    1. WHO Foodborne diseases burden epidemiology reference group 2007–2015. WHO estimates of the global burden of foodborne diseases. Available at: http://www.who.int/foodsafety/publications/foodborne_disease/fergreport/en/.
    1. Wild CP, Hudson GJ, Sabbioni G, et al. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev. 1992; 1: 229–234. [Medline]. - PubMed
    1. Groopman JD, Wild CP, Hasler J, Junshi C, Wogan GN, Kensler TW. Molecular epidemiology of aflatoxin exposures: validation of aflatoxin-N7-guanine levels in urine as a biomarker in experimental rat models and humans. Environmental Health Perspectives. 1993; 99: 107–113. 10.1289/ehp.9399107 - DOI - PMC - PubMed

Publication types

LinkOut - more resources